New-onset guttate psoriasis secondary to COVID-19

Autor:	Faten Rabhi, Raouf Dhaoui, Meriem Rouai, Kahena Jaber
Rok vydání:	2021
Předmět:	medicine.medical_specialty Coronavirus disease 2019 (COVID-19) business.industry viruses Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Hydroxychloroquine Disease medicine.disease Dermatology Virus New onset Psoriasis medicine business Guttate psoriasis medicine.drug
Popis:	SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID19), is associated with flares of psoriasis in patients with well-documented disease. Both viral infection and medications used for treatment, like hydroxychloroquine, were incriminated. Herein, we report the case of a 25-year-old patient who presented a first-onset guttate psoriasis following COVID19.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::802d72dfdef4156f3d18b1a5b87d62bc https://doi.org/10.22541/au.161713189.94601468/v1 Zobrazit plný text záznamu